Eko Foundation Analysis Software with Transformers (EFAST) vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by Volta Medical

AI Verdict

EFAST is designed for non-invasive, early detection of AFib and structural murmurs during routine clinical exams, assisting a broad range of clinicians. In contrast, VX1+ is an interventional tool specifically for electrophysiologists, providing real-time AI guidance during complex cardiac ablation procedures for AFib and atrial tachycardia. They address different stages of cardiac care, making them complementary rather than directly competitive.

Choose Eko Foundation Analysis Software with Transformers (EFAST) if…

Choose EFAST if your primary goal is to enhance routine cardiac screenings and facilitate early detection of structural murmurs and atrial fibrillation in a non-invasive setting. This tool is ideal for general clinicians and cardiologists seeking real-time, AI-powered insights during auscultation to quickly identify potential heart conditions and streamline patient referrals.

View Eko Foundation Analysis Software with Transformers (EFAST) →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or atrial tachycardia and require real-time, AI-driven assistance to identify abnormal electrograms. This software is specifically designed to integrate with existing EP lab systems, providing critical insights during invasive procedures to optimize ablation strategies.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Foundation Analysis Software with Transformers (EFAST) VX1+
Pricing Subscription-based, contact for details Unknown
Deployment Unknown Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST is designed for seamless integration into routine clinical workflows, offering real-time AI analysis during auscultation with enhanced audio and guided exams. Its focus on 'no additional steps' makes it broadly accessible for primary care and emergency settings. While VX1+ has a simple interface for its specialized use, EFAST's integration into a common, less invasive procedure provides broader usability.

Clinical Value

VX1+

Both tools offer significant clinical value, but VX1+ stands out for its direct impact on complex, invasive procedures. It provides real-time AI guidance during cardiac ablation for AF and AT, standardizing a previously operator-dependent process and demonstrating high freedom from AF/AT in clinical outcomes. EFAST, while valuable for early detection in routine exams, addresses a broader diagnostic need rather than guiding a high-stakes interventional procedure.

Pricing & Value

Eko Foundation Analysis Software with Transformers (EFAST)

Tool A (EFAST) offers greater transparency in its pricing model, outlining a subscription-based yearly membership and an approximate daily cost for its associated hardware. In contrast, Tool B (VX1+) provides no publicly available pricing information, making it impossible for potential customers to assess its value without direct contact.

Enterprise Readiness

Eko Foundation Analysis Software with Transformers (EFAST)

EFAST demonstrates stronger enterprise readiness by explicitly stating FDA clearance, HIPAA compliance, and the availability of a Business Associate Agreement (BAA). Its cloud-based Software as a Medical Device (SaMD) deployment and EMR integration further streamline its adoption into existing healthcare IT infrastructures. While VX1+ is FDA-cleared and integrates with existing systems, explicit statements regarding BAA and HIPAA compliance are not provided in the facts.

Innovation

VX1+

Both tools are highly innovative in their respective fields. However, VX1+ is recognized as the 'first FDA cleared AI-based tool in interventional cardiac electrophysiology,' providing real-time AI guidance during complex, invasive ablation procedures to standardize an operator-dependent process. This application of AI to directly guide a high-stakes interventional procedure represents a slightly higher bar for innovation in terms of complexity and direct impact on procedural outcomes.

Support & Docs

Eko Foundation Analysis Software with Transformers (EFAST)

Eko Health provides comprehensive support for EFAST, including a dedicated Help Center with user manuals, email support via a contact form, scheduled phone calls, and options for live demos and Q&A sessions. While Volta Medical offers a user manual and contact information for VX1+, Eko Health's range of accessible support resources appears more extensive.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Foundation Analysis Software with Transformers (EFAST) VX1+
Name Eko Foundation Analysis Software with Transformers (EFAST) VX1+
Primary Use Case Assists clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation during routine exams. Assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Company Eko Health Volta Medical
Key AI Functionality AI-powered structural murmur detection (93% sensitivity, 91% specificity); AI-powered atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity); Real-time AI analysis during auscultation. Real-time manual or automatic annotation of 3D anatomical and electrical maps; Identification of spatio-temporal dispersed electrograms (DEs) during AF and AT procedures; AI-driven insights to assist electrophysiologists.
Target Medical Specialties Cardiology, Family Medicine, Internal Medicine Cardiology

Videos

Demos, reviews, and walkthroughs featuring Eko Foundation Analysis Software with Transformers (EFAST) and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EFAST by Eko Health is designed to assist clinicians in identifying structural murmurs associated with heart disease and detecting atrial fibrillation during routine exams, targeting a broad patient population in cardiology, family medicine, and internal medicine. VX1+ by Volta Medical is an AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
EFAST offers seamless integration with Eko digital stethoscopes, such as the CORE 500, and provides EMR integration for streamlined documentation. VX1+ integrates with existing EP recording and 3D mapping systems, including Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system, and is compatible with existing 510(k)-cleared catheters.
EFAST provides real-time AI analysis during auscultation for structural murmur detection (93% sensitivity, 91% specificity) and atrial fibrillation (AFib) detection (95% sensitivity, 94% specificity). VX1+ offers AI-driven insights to assist electrophysiologists by identifying spatio-temporal dispersed electrograms (DEs) during AF and AT procedures, with real-time manual or automatic annotation of 3D anatomical and electrical maps.
Both EFAST and VX1+ are FDA-cleared. EFAST explicitly states it is HIPAA compliant and has a Business Associate Agreement (BAA). While HIPAA compliance and a BAA are expected for VX1+ as a medical device handling patient data in U.S. healthcare settings, these are not explicitly stated in the provided information for VX1+.

Backers

Who funded each tool's parent company.

Eko Foundation Analysis Software with Transformers (EFAST)

AI Tool Finder
AI-powered search. Results may not be comprehensive.